|
Dec 1
|
UPDATE 1-US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
|
|
Dec 1
|
Annovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why
|
|
Dec 1
|
Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble?
|
|
Dec 1
|
1 Underrated Reason to Buy Eli Lilly Stock
|
|
Dec 1
|
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Dec 1
|
Pfizer drops plan for twice-daily obesity pill due to side effects
|
|
Dec 1
|
December Looks Great For Investors Who Own 9 Stocks
|
|
Dec 1
|
UPDATE 4-Pfizer drops twice-daily version of obesity pill over side effects
|
|
Dec 1
|
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
|
|
Dec 1
|
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
|
|
Nov 30
|
Weight loss drugs likely to boost apparel stocks: Survey
|
|
Nov 30
|
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
|
|
Nov 30
|
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
|
|
Nov 29
|
20 Most Fit Countries in the World
|
|
Nov 29
|
12 Best Quality Stocks To Buy Now
|
|
Nov 9
|
Approval for Eli Lilly obesity drug sets up rival to Wegovy
|
|
Nov 8
|
Earnings Estimates Come Under Pressure
|
|
Nov 8
|
FDA approves Eli Lilly's Mounjaro for weight loss
|
|
Nov 8
|
Eli Lilly Shares Hit All-Time High After FDA Approves Drug for Weight-Loss Treatment
|
|
Nov 8
|
Eli Lilly Stock Jumps on Obesity Drug’s FDA Approval
|